Fanapt and Haematuria - a phase IV clinical study of FDA data

Summary:

Haematuria is reported only by a few people who take Fanapt.

The phase IV clinical study analyzes which people take Fanapt and have Haematuria. It is created by eHealthMe based on reports of 1,357 people who have side effects while taking Fanapt from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 16, 2022

1,357 people reported to have side effects when taking Fanapt.
Among them, 2 people (0.15%) have Haematuria.


What is Fanapt?

Fanapt has active ingredients of iloperidone. It is often used in schizophrenia. eHealthMe is studying from 1,370 Fanapt users for its effectiveness, alternative drugs and more.

What is Haematuria?

Haematuria (presence of blood in urine) is found to be associated with 2,887 drugs and 2,227 conditions by eHealthMe.

Number of Fanapt and Haematuria reports submitted per year:

Could Fanapt cause Haematuria?

Time on Fanapt when people have Haematuria *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Haematuria when taking Fanapt *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Haematuria when taking Fanapt *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Fanapt *:

  1. Haldol: 1 person, 50.00%
  2. Cogentin: 1 person, 50.00%
  3. Avandia: 1 person, 50.00%
  4. Actos: 1 person, 50.00%

Common side effects people have besides Haematuria *:

  1. Urination - Painful: 1 person, 50.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 50.00%
  3. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 1 person, 50.00%
  4. Cardiac Failure Congestive: 1 person, 50.00%
  5. Cardiac Disorder: 1 person, 50.00%
  6. Bladder Cancer: 1 person, 50.00%
  7. Abdominal Pain Lower: 1 person, 50.00%

Common conditions people have *:

  1. Type 2 Diabetes: 1 person, 50.00%
  2. Diabetes: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fanapt and have Haematuria?

Check whether Haematuria is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Haematuria and when was it recovered:

Expand to all the drugs that have ingredients of iloperidone:

Alternative drugs to, pros and cons of Fanapt:

Haematuria treatments and more:

COVID vaccines that are related to Haematuria:

Common drugs associated with Haematuria:

All the drugs that are associated with Haematuria:

Common conditions associated with Haematuria:

All the conditions that are associated with Haematuria:

How the study uses the data?

The study uses data from the FDA. It is based on iloperidone (the active ingredients of Fanapt) and Fanapt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: